CAT

912.08

-1.45%↓

297.49

-1.13%↓

GEV.US

1,072.34

+0.04%↑

RTX

178.71

+0.06%↑

236.94

-0.49%↓

CAT

912.08

-1.45%↓

297.49

-1.13%↓

GEV.US

1,072.34

+0.04%↑

RTX

178.71

+0.06%↑

236.94

-0.49%↓

CAT

912.08

-1.45%↓

297.49

-1.13%↓

GEV.US

1,072.34

+0.04%↑

RTX

178.71

+0.06%↑

236.94

-0.49%↓

CAT

912.08

-1.45%↓

297.49

-1.13%↓

GEV.US

1,072.34

+0.04%↑

RTX

178.71

+0.06%↑

236.94

-0.49%↓

CAT

912.08

-1.45%↓

297.49

-1.13%↓

GEV.US

1,072.34

+0.04%↑

RTX

178.71

+0.06%↑

236.94

-0.49%↓

Home・Akciju saraksts・CryoPort Inc

CryoPort Inc

Slēgts

SektorsRūpniecība

13.04 -0.91

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.74

Max

13.11

Galvenie mērījumi
By Trading Economics
Ienākumi	14M -9.4M
Pārdošana	2.3M 48M
EPS	-0.189
Peļņas marža	-19.733
Darbinieki	684
EBITDA	443K -3.2M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+3.11% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 4. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	143M 664M
Iepriekšējā atvēršanas cena	13.95
Iepriekšējā slēgšanas cena	13.04

Ziņu noskaņojums

By Acuity

20%

80%

45 / 405 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

5.615 / N/A Atbalsts un pretestība

CryoPort Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. maijs 22:50 UTC

Peļņas

Commonwealth Bank of Australia Increases Provisions as 3Q Profit Slips

2026. g. 12. maijs 22:49 UTC

Peļņas

Aristocrat Leisure Raises Midyear Dividend, Swells Share Buyback Program

2026. g. 12. maijs 22:32 UTC

Peļņas

JBS 1Q Profit Slides Amid Rising Cattle Costs -- Update

2026. g. 12. maijs 23:48 UTC

Tirgus saruna

Nikkei May Decline Amid Uncertainty Over Iran Conflict -- Market Talk

2026. g. 12. maijs 22:57 UTC

Tirgus saruna

Peļņas

JBS Says Consumers Are Looking to Pork for Affordable Protein -- Market Talk

2026. g. 12. maijs 22:26 UTC

Peļņas

Aristocrat Leisure to Increase On-Market Share Buyback by A$1 Billion

2026. g. 12. maijs 22:25 UTC

Peļņas

Aristocrat Leisure 1H Normalized Pretax Profit A$997.3 Million, Up 9.4% on Year

2026. g. 12. maijs 22:25 UTC

Peļņas

Aristocrat Leisure Interim Dividend A$0.50/Security

2026. g. 12. maijs 22:24 UTC

Peļņas

Aristocrat Leisure 1H Revenue From Continuing Operations A$3.03 Billion, Down 0.2% on Year

2026. g. 12. maijs 22:23 UTC

Peļņas

Aristocrat Leisure 1H Net Profit From Discontinued Operations A$7.0 Million

2026. g. 12. maijs 22:23 UTC

Peļņas

Aristocrat Leisure 1H Net Profit From Continuing Operations A$798.5 Million, Up 56%

2026. g. 12. maijs 22:19 UTC

Peļņas

CBA: Total Provision Coverage Ratio 1.57%>CBA.AU

2026. g. 12. maijs 22:14 UTC

Peļņas

CBA: Business Lending Continued to Grow Above System>CBA.AU

2026. g. 12. maijs 22:14 UTC

Peļņas

CBA Had 1.4M Business Transaction Accounts at March 31, Up 7% on Year>CBA.AU

2026. g. 12. maijs 22:13 UTC

Peļņas

CBA Household Deposits Grew A$38B in 12 Months Through March>CBA.AU

2026. g. 12. maijs 22:12 UTC

Peļņas

CBA Home Loan Balances Grew A$41B in 12 Months Through March>CBA.AU

2026. g. 12. maijs 22:12 UTC

Peļņas

CBA 3Q New Home Loan Funding A$45B>CBA.AU

2026. g. 12. maijs 22:11 UTC

Peļņas

Correct: JBS NV 1Q EPS 20c, Not 21c >JBS

2026. g. 12. maijs 22:11 UTC

Peļņas

CBA: CET1 Level 2 Capital Ratio 11.6%>CBA.AU

2026. g. 12. maijs 22:10 UTC

Peļņas

CBA: Customer Deposit Funding Ratio 79%>CBA.AU

2026. g. 12. maijs 22:09 UTC

Peļņas

CBA: Underlying Portfolio Credit Quality Remains Sound>CBA.AU

2026. g. 12. maijs 22:09 UTC

Peļņas

CBA: Higher Collective Provisions Reflect Geopolitical, Macroeconomic Uncertainty >CBA.AU

2026. g. 12. maijs 22:08 UTC

Peļņas

CBA 3Q Loan Impairment Expense A$316M>CBA.AU

2026. g. 12. maijs 22:07 UTC

Peļņas

CBA: Costs Up on Higher Cloud Computing Volumes, Software Licenses, AI Investment>CBA.AU

2026. g. 12. maijs 22:06 UTC

Peļņas

CBA 3Q Operating Expenses Up 1% Excluding Restructuring, Notable Items>CBA.AU

2026. g. 12. maijs 22:06 UTC

Peļņas

CBA: 3Q Underlying Net Interest Margin Was Broadly Stable>CBA.AU

2026. g. 12. maijs 22:05 UTC

Peļņas

CBA: Lending, Deposit Volume Growth Offset Impact of Two Fewer Days >CBA.AU

2026. g. 12. maijs 22:04 UTC

Peļņas

Commonwealth Bank: Operating Income Flat in March Quarter >CBA.AU

2026. g. 12. maijs 22:04 UTC

Peļņas

Commonwealth Bank 3Q Cash Profit Up 4% on Year>CBA.AU

2026. g. 12. maijs 22:04 UTC

Peļņas

Commonwealth Bank 3Q Cash Profit Down 1% on 1H Quarterly Average>CBA.AU

Salīdzinājums

Cenas izmaiņa

CryoPort Inc Prognoze

Cenas mērķis

By TipRanks

3.11% augšup

Prognoze 12 mēnešiem

Vidējais 13.58 USD 3.11%

Augstākais 17 USD

Zemākais 9.5 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CryoPort Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 7 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CryoPort Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

5.615 / N/AAtbalsts un pretestība

Recent bullish events outweigh bearish events.

There is one bullish event.

Noskaņojums

By Acuity

45 / 405 Rangs Rūpniecība

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.